Figure 1.
Coronary artery aneurysm (CAA) is defined as coronary dilatation which exceeds the diameter of normal adjacent segments or the diameter of the patient’s largest coronary vessel by 1.5 times1. The overall incidence of CAAs ranges from 1.5 to 5%, with a male preponderance and predilection for the right coronary artery1. We present a case report of iatrogenic CAAs which developed after Absorb™️ bioresorbable vascular scaffold (BVS; Abbott Vascular, Santa Clara, CA, USA) implantation.
In 2013, a 65-year-old gentleman with hypertension, obesity, effort angina and positive stress test, underwent a coronary angiogram which revealed an occluded mid right coronary artery (RCA) and critical stenosis of the proximal left circumflex artery. Two overlapping Absorb BVS were deployed in the RCA (Panel A) and a staged PCI of the LCX with deployment of one Absorb BVS followed one month later. A coronary angiogram and OCT of the RCA were carried out five years later, as part of the study. This revealed an aneurysm in the mid RCA (Panel B, arrow) and LCX (Supplementary Figure 1). OCT showed complete resorption of the Absorb scaffold, with areas of near normal segments in the proximal RCA, having a maximum lumen diameter of 3.6 mm and lumen area of 8.4 mm² (Panel C). The mid RCA, after the aneurysmal segment, had a lumen diameter of 3.2 mm and area of 7.7 mm² (Panel D). There was a significant aneurysmal dilatation of the mid RCA with a maximum diameter of 5.6 mm (area 16.89 mm2) (Panel E). The distal RCA showed ectatic dilatation with an MLD of 3.9 mm (area 10.2 mm2) (Panel F).
In case reports, the time to aneurysm formation in BVS varies from 6 to 32 months. The reasons are not clear but could be due to aggressive bed preparation with resultant deep dissections. The distinct morphological characteristics of the BVS –thicker struts and slower expandability– require higher pressures for balloon inflation, which could damage the arterial wall2. Late development of scaffold strut discontinuity and the resultant outward displacement of struts may result in aneurysm formation. The polymer and the antiproliferative drug could also play a role3.
Supplementary data
Left circumflex artery angiogram at scaffold deployment and at 5-year follow-up.
Acknowledgments
Conflict of interest statement
The authors have no conflicts of interest to declare.
Contributor Information
Gunasekaran Sengottovelu, Apollo Hospital, Chennai, Tamil Nadu, India.
Paul Pandi Vinodh Kumar, Apollo Hospital, Chennai, Tamil Nadu, India.
Immaneni Sathyamurthy, Apollo Hospital, Chennai, Tamil Nadu, India.
References
- Syed M, Lesch M. Coronary artery aneurysm: a review. Prog Cardiovasc Dis. 1997;40:77–84. doi: 10.1016/s0033-0620(97)80024-2. [DOI] [PubMed] [Google Scholar]
- Varghese S, Lauer B, Ohlow MA. Coronary Artery Aneurysm After Everolimus-Eluting Bioabsorbable Vascular Scaffold Implantation. JACC Cardiovasc Interv. 2016;9:e23–5. doi: 10.1016/j.jcin.2015.10.032. [DOI] [PubMed] [Google Scholar]
- Abou Sherif, Ozden Tok, Taşköylü Ö, Goktekin O, Kilic ID. Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment. Front Cardiovasc Med. 2017;4:24. doi: 10.3389/fcvm.2017.00024. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Left circumflex artery angiogram at scaffold deployment and at 5-year follow-up.
